Dynamics of Tumor-Infiltrating Lymphocytes as Indicators of Neoadjuvant Therapy Response in Luminal Breast Cancer - Top-Institutions - MDSpire

Dynamics of Tumor-Infiltrating Lymphocytes as Indicators of Neoadjuvant Therapy Response in Luminal Breast Cancer

By
Esma Uguztemur
Merve Dogan
February 27, 2026
0 min

Bmc Cancer

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

#1

Dana-Farber Cancer Institute

Boston, MA
Key Differentiators
- Breast Oncology
- Immuno-Oncology
- Translational Cancer Research
#2

Memorial Sloan Kettering Cancer Center

New York, NY
Key Differentiators
- Breast Cancer Surgery and Oncology
- Cancer Immunology
- Pathology
#3

MD Anderson Cancer Center

Houston, TX
Key Differentiators
- Breast Medical Oncology
- Cancer Immunotherapy
- Translational Research
#4

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center

Baltimore, MD
Key Differentiators
- Breast Cancer Research
- Tumor Immunology
- Clinical Trials
#5

University of California, San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center

San Francisco, CA
Key Differentiators
- Breast Oncology
- Cancer Immunology
- Translational Medicine

Original Source(s)

Bmc Cancer

Dynamics of Tumor-Infiltrating Lymphocytes as Indicators of Neoadjuvant Therapy Response in Luminal Breast Cancer

by Esma Uguztemur, Merve Dogan
February 27, 2026

Related Content

Frontiers In Oncology

Differential diagnosis of testicular embryonal rhabdomyosarcoma and testicular seminoma with enhanced CT: a retrospective study

by Zhixu Zhang, Pan Liang, Songwei Yue, Yonggao Zhang, Hongyan Zhang, Zhigang Zhou, Jianbo Gao
June 3, 2026

Frontiers In Oncology

Liquid biopsy-guided kidney-sparing management in upper tract urothelial carcinoma: from preoperative risk stratification to perioperative surveillance

by Difei Yu, Jiarun Tang, Yu Zhang, Ke Hu, Jing Qing, Jiamo Zhang
June 2, 2026

Frontiers In Oncology

Impact of body mass index on dietary habits and health behaviors in breast cancer patients